Work

020 Long-term efficacy of ocrelizumab in relapsing multiple sclerosis: 6 study years

Year: 2022

Type: article

Source: Journal of Neurology Neurosurgery & Psychiatry

DOI: 10.1136/jnnp-2022-abn.59

Authors: Gavin Giovannoni, Ludwig Kappos, Jerome de Seze, Stephen L Hauser, James Overell, Harold Koendgen, Kalpesh Prajapati, Marianna Manfrini, Qing Wang, Jerry S Wolinsky

Institutions: Queen Mary University of London, Blizard Institute, University of Basel, University Hospital of Basel, Hôpitaux Universitaires de Strasbourg, University of California, San Francisco, F. Hoffmann-La Roche AG, Stedelijk Museum Amsterdam, The University of Texas Health Science Center at Houston

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281623600

FWCI:

Cites:

Cited by:

Related to: 10